David H. Persing, Executive VP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 5,129 shares at $36.62 ($188K) on 2013-08-30, disclosed to the SEC on 2013-09-04.
Open-market sale of $188k CPHD by Executive VP, Chief Med/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |